| Tap a line for its trend | Last 12Mto Jun 2026 | FY25Mar 2025 | FY24Mar 2024 | FY23Mar 2023 | FY22Mar 2022 | FY21 and earlierAlpha Plus |
|---|
| 183.68× | 183.68× | 173.95× | 169.19× | 164.30× | FY21 and earlierEvery year the company has filed comes with Alpha Plus. | |
| 43.82× | 43.82× | 39.34× | 34.18× | 29.73× | ||
| 1.02× | 1.02× | 1.12× | 1.14× | 1.16× | ||
| 2.38× | 2.38× | 1.17× | 2.59× | 0.24× | ||
| 1.06× | 1.06× | 0.58× | 1.19× | 0.13× |
From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.
Ratios — % unless marked × 12 Months Ending | FY22 31/03/2022 | FY23 31/03/2023 | FY24 31/03/2024 | FY25 31/03/2025 | Last 12M 30/06/2026 | |
|---|---|---|---|---|---|---|
| Inventory Days (DIO) | 164.30 | 169.19 | 173.95 | 183.68 | 183.68 | |
| Receivable Days (DSO) | 29.73 | 34.18 | 39.34 | 43.82 | 43.82 | |
| Asset Turnover | 1.16 | 1.14 | 1.12 | 1.02 | 1.02 | |
| Cash Conversion (CFO/Net Income) | 0.24 | 2.59 | 1.17 | 2.38 | 2.38 | |
| CFO/EBITDA | 0.13 | 1.19 | 0.58 | 1.06 | 1.06 |